NBY - NovaBay Pharma gains 10% on launch of new oral supplement to comfort dry eyes
2023-03-07 07:31:59 ET
- NovaBay Pharmaceuticals ( NYSE: NBY ) jumps 10% premarket after announcing the launch of OTC Avenova Eye Health Support oral supplement featuring a combination of MaquiBright, a nutrient-rich, antioxidant-dense extract of the superfruit maqui berry, and high quality, natural triglyceride omega-3 oils to comfort dry eyes and support overall eye health.
- Avenova Eye Health Support is sold as 60 easy-to-swallow softgel capsules and is available at Amazon.com and Avenova.com for $41.95, and through optometrist offices.
- Participants in a four-week, placebo-controlled study on the effects of MaquiBright extract showed an 89% increase in tear production and reported a 57% improvement in dry eye discomfort with Avenova Eye Health Support. Study results were published in the peer-reviewed Journal of Traditional and Complementary Medicine.
- With the strategic addition of an oral supplement, the Avenova brand now offers a product for each step of the standard dry-eye treatment regimen.
For further details see:
NovaBay Pharma gains 10% on launch of new oral supplement to comfort dry eyes